Abstract Details

Title Rebound of disease activity after fingolimod (FTY) withdrawal: can we predict it?

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 371

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Julio Dotor Garcia-Soto PRESENTER	JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Virginia Meca Lallana	Virginia Meca Lallana has nothing to disclose.
	No disclosure on file
	No disclosure on file